AlphaCentric Advisors »

Veracyte shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Veracyte (VCYT) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Veracyte

Tip: Access up to 7 years of quarterly data

All positions including Veracyte held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veracyte by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $220k 6.8k 32.21

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Astrazeneca Ord (AZN)
Vertex Pharmaceuticals Incorporated (VRTX)
Euronet Worldwide (EEFT)
Invitation Homes (INVH)
Ionis Pharmaceuticals (IONS)
Insmed Com Par $.01 (INSM)
Incyte Corporation (INCY)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
AMREP Corporation (AXR)
Saul Centers (BFS)

View all positions for AlphaCentric Advisors

Top funds holding Veracyte

BlackRock
Vanguard Group
FMR
Artisan Partners Limited Partnership
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
ARK Investment Management
Dimensional Fund Advisors
First Trust Advisors
Wellington Management Company
Geode Capital Management
Bank of America Corporation
Jennifer Ranahan
Hanna Zanoni

View all funds holding Veracyte